DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy

Andrew Radley (Lead / Corresponding author), Jan Tait, John F. Dillon

Research output: Contribution to journalArticlepeer-review

45 Citations (Scopus)
308 Downloads (Pure)

Fingerprint

Dive into the research topics of 'DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences